New patent for Global Blood drug OXBRYTA

Annual Drug Patent Expirations for OXBRYTA Oxbryta is a drug marketed by Global Blood Theraps and is included in two NDAs. It is available from one supplier. There are ten…

Source


Comments are closed.

Biotechblog